Drug intelligence / Profile preview

fac-[Re(phen)(CO)3(MMP)]

Development stage
Preclinical
Lead developer
University of Cape Town
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
01

Overview

fac-[Re(phen)(CO)3(MMP)] (Complex 2b) is a neutral rhenium(I) tricarbonyl complex featuring a 1,10-phenanthroline (phen) bidentate ligand and a methyl 3-mercaptopropionate (MMP) sulfur-donor ligand. This organometallic compound is part of a series of rhenium complexes investigated for their potential as anti-cancer agents and multimodal cellular imaging probes. It exhibits intrinsic phosphorescence, which facilitates live-cell confocal microscopy and organelle localization studies. In preclinical assays, the complex demonstrates anti-proliferative activity against human breast cancer cell lines, including MDA-MB-231 and MCF-7. Its biological activity is characterized by cellular uptake and localization within lysosomes and mitochondria. Research indicates that while these sulfur-donor complexes may have lower baseline potency than their aqua-complex counterparts, they maintain stability in the presence of extracellular glutathione and show enhanced efficacy in thiol-depleted environments, suggesting potential for co-treatment strategies with thiol-depleting agents.

Other names
fac-tricarbonyl(1,10-phenanthroline)(methyl 3-mercaptopropionato)rhenium(I)fac-[Re(CO)3(phen)(MMP)]
02

Targets

DNA

Beyond the preview

Go deeper on fac-[Re(phen)(CO)3(MMP)].

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fac-[Re(phen)(CO)3(MMP)].

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call